The role of protons in modern and biologically-guided radiotherapy

References

• Grau C, Muren LP, Høyer M, Lindegaard J, Overgaard J. Image-guided adaptive radiotherapy – integration of biology and technology to improve clinical outcome. Acta Oncol 2008;47:1182–5.
   PubMed Web of Science ®Google Scholar
• Daşu A. Treatment planning optimisation based on imaging tumour proliferation and cell density. Acta Oncol 2008; 47:1221–8.
   PubMed Web of Science ®Google Scholar
• Emami B, Lyman J, Brown A, Coia L, Goitein M, Munzenrider JE, . Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 1991;21: 109–22.
   PubMed Web of Science ®Google Scholar
• Marks LB, Yorke ED, Jackson A, Ten Haken RK, Constine LS, Eisbruch A, . Use of normal tissue complication probability models in the clinic. Int J Radiat Oncol Biol Phys 2010;76(3 Suppl):S10–9.
   PubMed Web of Science ®Google Scholar
• Kutcher GJ. Quantitative plan evaluation: TCP/NTCP models. Front Radiat Ther Oncol 1996;29:67–80.
   PubMedGoogle Scholar
• Baumann M, Petersen C, Krause M. TCP and NTCP in preclinical and clinical research in Europe. Rays 2005;30: 121–6.
   PubMedGoogle Scholar
• Niemierko A. Reporting and analyzing dose distributions: A concept of equivalent uniform dose. Med Phys 1997;24:103–10.
   PubMed Web of Science ®Google Scholar
• Wang JZ, Mayr NA, Yuh WT. Behind EUD. Acta Oncol 2008;47:971–2.
   PubMed Web of Science ®Google Scholar
• Levin-Plotnik D, Hamilton RJ. Optimization of tumour control probability for heterogeneous tumours in fractionated radiotherapy treatment protocols. Phys Med Biol 2004; 49:407–24.
   PubMed Web of Science ®Google Scholar
• Webb S. Optimum parameters in a model for tumour control probability including interpatient heterogeneity. Phys Med Biol 1994;39:1895–914.
   PubMed Web of Science ®Google Scholar
• Webb S, Nahum AE. A model for calculating tumour control probability in radiotherapy including the effects of inhomogeneous distributions of dose and clonogenic cell density. Phys Med Biol 1993;38:653–66.
   PubMed Web of Science ®Google Scholar
• Hall EJ. Dose-painting by numbers: A feasible approach? Lancet Oncol 2005;6:66.
   PubMed Web of Science ®Google Scholar
• Bentzen SM. Theragnostic imaging for radiation oncology: Dose-painting by numbers. Lancet Oncol 2005;6:12–7.
   Web of Science ®Google Scholar
• Fenwick JD, Nahum AE, Malik ZI, Eswar CV, Hatton MQ, Laurencejj VM, . Escalation and intensification of radiotherapy for stage III non-small cell lung cancer: Opportunities for treatment improvement. Clin Oncol 2009; 21:343–60.
   Web of Science ®Google Scholar
• van Baardwijk A, Wanders S, Boersma L, Borger J, Ollers M, Dingemans AM, . Mature results of an individualized radiation dose prescription study based on normal tissue constraints in stages I to III non-small-cell lung cancer. J Clin Oncol 2010;28:1380–6.
   PubMed Web of Science ®Google Scholar
• Miles EA, Clark CH, Urbano TG, Bidmead M, Dearnaley DP, Harrington KJ, . The impact of introducing intensity modulated radiotherapy into routine clinical practice. Radiother Oncol 2005;77:241–6.
   PubMed Web of Science ®Google Scholar
• Lomax A. Intensity modulation methods for proton radiotherapy. Phys Med Biol 1999;44:185–205.
   PubMed Web of Science ®Google Scholar
• Tilly N, Johansson J, Isacsson U, Medin J, Blomquist E, Grusell E, . The influence of RBE variations in a clinical proton treatment plan for a hypopharynx cancer. Phys Med Biol 2005;50:2765–77.
   PubMed Web of Science ®Google Scholar
• Weber DC, Wang H, Cozzi L, Dipasquale G, Khan HG, Ratib O, . RapidArc, intensity modulated photon and proton techniques for recurrent prostate cancer in previously irradiated patients: A treatment planning comparison study. Radiat Oncol 2009;4:34.
   PubMed Web of Science ®Google Scholar
• Zhang X, Li Y, Pan X, Xiaoqiang L, Mohan R, Komaki R, . Intensity-modulated proton therapy reduces the dose to normal tissue compared with intensity-modulated radiation therapy or passive scattering proton therapy and enables individualized radical radiotherapy for extensive stage IIIb non-small-cell lung cancer: A virtual clinical study. Int J Radiat Oncol Biol Phys 2010;77:357–66.
   PubMed Web of Science ®Google Scholar
• Ares C, Khan S, Macartain AM, Heuberger J, Goitein G, Gruber G, . Postoperative proton radiotherapy for localized and locoregional breast cancer: Potential for clinically relevant improvements? Int J Radiat Oncol Biol Phys 2010; 76:685–97.
   PubMed Web of Science ®Google Scholar
• Dowdell SJ, Metcalfe PE, Morales JE, Jackson M, Rosenfeld AB. A comparison of proton therapy and IMRT treatment plans for prostate radiotherapy. Australas Phys Eng Sci Med 2008;31:325–31.
   PubMed Web of Science ®Google Scholar
• Muzik J, Soukup M, Alber M. Comparison of fixed-beam IMRT, helical tomotherapy, and IMPT for selected cases. Med Phys 2008;35:1580–92.
   PubMed Web of Science ®Google Scholar
• Glimelius B, Ask A, Bjelkengren G, Björk-Eriksson T, Blomquist E, Johansson B, . Number of patients potentially eligible for proton therapy. Acta Oncol 2005;44: 836–49.
   PubMed Web of Science ®Google Scholar
• Rijkee AG, Zoetelief J, Raaijmakers CP, Van Der Marck SC, Van Der Zee W. Assessment of induction of secondary tumours due to various radiotherapy modalities. Rad Prot Dosim 2006;118:219–26.
   PubMed Web of Science ®Google Scholar
• Tubiana M. Can we reduce the incidence of second primary malignancies occurring after radiotherapy? A critical review. Radiother Oncol 2009;91:4–15.
   PubMed Web of Science ®Google Scholar
• Mu X, Björk-Eriksson T, Nill S, Oelfke U, Johansson KA, Gagliardi G, . Does electron and proton therapy reduce the risk of radiation induced cancer after spinal irradiation for childhood medulloblastoma? A comparative treatment planning study. Acta Oncol 2005;44:554–62.
   PubMed Web of Science ®Google Scholar
• Brenner DJ, Curtis RE, Hall EJ, Ron E. Second malignancies in prostate carcinoma patients after radiotherapy compared with surgery. Cancer 2000;88:398–406.
   PubMed Web of Science ®Google Scholar
• Verellen D, Vanhavere H. Risk assessment of radiation-induced malignancies based on whole-body equivalent dose estimates for IMRT treatment in the head and neck region. Radiother Oncol 1999;53:199–203.
   PubMed Web of Science ®Google Scholar
• Verheij M, Vens C, van Triest B. Novel therapeutics in combination with radiotherapy to improve cancer treatment: Rationale, mechanisms of action and clinical perspective. Drug Resist Updat 2010;13:29–43.
   PubMed Web of Science ®Google Scholar
• Schulz RJ, Kagan AR. More precisely defined dose distributions are unlikely to affect cancer mortality. Med Phys 2003;30:276.
   PubMed Web of Science ®Google Scholar
• Blanco R, Solé J, Montesinos J, Mesía C, Algara M, Terrassa J, . ACROSS. Induction chemotherapy with cisplatin and gemcitabine followed by concurrent chemoradiation with twice-weekly gemcitabine in unresectable stage III non-small cell lung cancer: Final results of a phase II study. Lung Cancer 2008;62:62–71.
   PubMed Web of Science ®Google Scholar
• Socinski MA, Blackstock AW, Bogart JA, Wang X, Munley M, Rosenman J, . Randomized phase II trial of induction chemotherapy followed by concurrent chemotherapy and dose-escalated thoracic conformal radiotherapy (74 Gy) in stage III non-small-cell lung cancer: CALGB 30105. J Clin Oncol 2008;26:2457–63.
   PubMed Web of Science ®Google Scholar
• Pfister DG, Su YB, Kraus DH, Wolden SL, Lis E, Aliff TB, . Concurrent cetuximab, cisplatin and concomitant boost radiotherapy for locoregionally advanced, squamous cell head and neck cancer: A pilot phase II study of a new combined-modality paradigm. J Clin Oncol 2006;24:1072–8.
   PubMed Web of Science ®Google Scholar
• Arrieta O, Gallardo-Rincón D, Villarreal-Garza C, Michel RM, Astorga-Ramos AM, Martínez-Barrera L, . High frequency of radiation pneumonitis in patients with locally advanced non-small cell lung cancer treated with concurrent radiotherapy and gemcitabine after induction with gemcitabine and carboplatin. J Thorac Oncol 2009;4:845–52.
   PubMed Web of Science ®Google Scholar
• Wang S, Liao Z, Wei X, Liu HH, Tucker SL, Hu CS, . Analysis of clinical and dosimetric factors associated with treatment-related pneumonitis (TRP) in patients with non-small-cell lung cancer (NSCLC) treated with concurrent chemotherapy and three-dimensional conformal radiotherapy (3D-CRT). Int J Radiat Oncol Biol Phys 2006;66: 1399–407.
   PubMed Web of Science ®Google Scholar
• Wang SL, Liao Z, Vaporciyan AA, Tucker SL, Liu H, Wei X, . Investigation of clinical and dosimetric factors associated with postoperative pulmonary complications in esophageal cancer patients treated with concurrent chemoradiotherapy followed by surgery. Int J Radiat Oncol Biol Phys 2006;64:692–9.
   PubMed Web of Science ®Google Scholar
• Daşu A, Toma-Daşu I, Olofsson J, Karlsson M. The use of risk estimation models for the induction of secondary cancers following radiotherapy. Acta Oncol 2005;44:339–47.
   PubMed Web of Science ®Google Scholar
• van Leeuwen FE, Klokman WJ, Stovall M, Dahler EC, van't Veer MB, Noordijk EM, . Roles of radiation dose, chemotherapy, and hormonal factors in breast cancer following Hodgkin's disease. J Natl Cancer Inst 2003;95:971–80.
   PubMed Web of Science ®Google Scholar
• Travis LB, Hill D, Dores GM, Gospodarowicz M, van Leeuwen FE, Holowaty E, . Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma. J Natl Cancer Inst 2005;97:1428–37.
   PubMed Web of Science ®Google Scholar
• Gilbert ES, Stovall M, Gospodarowicz M, Van Leeuwen FE, Andersson M, Glimelius B, . Lung cancer after treatment for Hodgkin's disease: Focus on radiation effects. Radiat Res 2003;159:161–73.
   PubMed Web of Science ®Google Scholar
• Sachs RK, Brenner DJ. Solid tumor risks after high doses of ionizing radiation. Proc Natl Acad Sci USA. 2005;102: 13040–5.
   PubMed Web of Science ®Google Scholar
• Schneider U, Kaser-Hotz B. Radiation risk estimates after radiotherapy: Application of the organ equivalent dose concept to plateau dose-response relationships. Radiat Environ Biophys 2005;44:235–9.
   PubMed Web of Science ®Google Scholar